Amarantus BioScience Holdings Inc. announced that it has appointed Brian E. Harvey, MD PhD to its strategic advisory board. Dr. Harvey will assist the company's management team in developing and executing its strategy to accelerate FDA regulatory approval for its orphan drug portfolio of products. Dr. Harvey recently served as Vice President of U.S Regulatory Strategy at Pfizer.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | -80.00% |
1st Jan change | Capi. | |
---|---|---|
-80.00% | 63.04K | |
+31.28% | 50.85B | |
+1.24% | 42.82B | |
+48.77% | 42.03B | |
-4.22% | 29.55B | |
+10.98% | 26.11B | |
-22.31% | 19.13B | |
+7.56% | 13.05B | |
+26.80% | 12.16B | |
+23.00% | 12.08B |
- Stock Market
- Equities
- AMBS Stock
- News Amarantus BioScience Holdings, Inc.
- Amarantus BioScience Holdings, Inc. Appoints Brian E. Harvey to its Strategic Advisory Board